Sequences

Sample result

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Human insulin's gene

DNA → Patent DNA · Automatic (BLAST)

Download as Excel

Every list and the search record, one sheet each.

Query
INS · 333 lettersATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGACCCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG
Set
Public patent sequences: Patent DNA, snapshot 2026-11-05-c456f6bdba29
Ran
2026-11-12
Found
3,194 sequences, 1,584 publications, 1,066 families

BLAST can miss matches that an exact scan or Smith-Waterman finds.

Charts

Identity against coverage

3,194 hits by identity and query coverage. 3,194 with a date.

Has a date00101020203030404050506060707080809090100100Identity (%)Query coverage (%)
Show table
Hits by identity
BandHas a dateAll
100%382382
95 to 99.9%273273
90 to 94.9%264264
80 to 89.9%1,4061,406
70 to 79.9%863863
50 to 69.9%66
Hits by query coverage
BandHas a dateAll
100%176176
95 to 99.9%510510
90 to 94.9%22
80 to 89.9%1111
70 to 79.9%193193
50 to 69.9%5656
Under 50%2,2462,246

Hits by year

1,066 families by year of first publication, 1979 to 2026.

Has a dateFamilies020406080197919831987199119951999200320072011201520192023
Show table
Families by year of first publication
YearHas a dateAll
197922
198133
198266
198311
198455
198544
198677
198744
198833
198955
199088
199233
199544
199633
199744
199866
199988
20001111
20012222
20023636
20032828
20043333
20053434
20063333
20073535
20083535
20094242
20104242
20116363
20123939
20133737
20143434
20154747
20163737
20175656
20184343
20195353
20204242
20215757
20223838
20232727
20243333
20252828
202655

Where hits align on the query

The top 20 hits on INS, a query of 333 bases: 20 cover the whole query, none differs from it.

Aligned partDiffers from the queryINS · 333 bases150100150200250300333A57719.1AR102881.1AR300598.1AX384892.1BD224077.1CQ714703.1GX863382.1DL255436.1FU371285.1FU424096.1HI201319.1HI394608.1HI394612.1HD058979.1FW369459.1FW369460.1GZ866940.1HK527381.1HK527379.1HK527380.1
Show table
The top 20 hits on INS, positions on the query
HitQuery fromQuery toIdentityDiffers atGaps atN at
A57719.11333100.0%NoneNoneNone
AR102881.11333100.0%NoneNoneNone
AR300598.11333100.0%NoneNoneNone
AX384892.11333100.0%NoneNoneNone
BD224077.11333100.0%NoneNoneNone
CQ714703.11333100.0%NoneNoneNone
GX863382.11333100.0%NoneNoneNone
DL255436.11333100.0%NoneNoneNone
FU371285.11333100.0%NoneNoneNone
FU424096.11333100.0%NoneNoneNone
HI201319.11333100.0%NoneNoneNone
HI394608.11333100.0%NoneNoneNone
HI394612.11333100.0%NoneNoneNone
HD058979.11333100.0%NoneNoneNone
FW369459.11333100.0%NoneNoneNone
FW369460.11333100.0%NoneNoneNone
GZ866940.11333100.0%NoneNoneNone
HK527381.11333100.0%NoneNoneNone
HK527379.11333100.0%NoneNoneNone
HK527380.11333100.0%NoneNoneNone

Patents 1.6K

Columns
Tick the columns each row shows, then choose Show. The arrows move a column.

1,584 publications in 1,066 families match these filters.

  1. US 9200083-B22015-12-01

    Methods of treating diabetes using therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptides

    DUKE UNIVERSITY

    Query Match 77.5%Identity 100.0%

    Best alignment

    Query 73 to 330, hit 45 to 302. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 104
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 164
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 224
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 284
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   285 CTGGAGAACTACTGCAAC 302
    

    258 of 258 identical, no gaps.

  2. US 9328154-B22016-05-03

    Therapeutic agents comprising fusions of growth hormone and elastic peptides

    DUKE UNIVERSITY

    Query Match 77.5%Identity 100.0%

    Best alignment

    Query 73 to 330, hit 45 to 302. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 104
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 164
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 224
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 284
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   285 CTGGAGAACTACTGCAAC 302
    

    258 of 258 identical, no gaps.

  3. US 9458218-B22016-10-04

    Therapeutic agents comprising fusions of insulin and elastic peptides

    DUKE UNIVERSITY

    Query Match 77.5%Identity 100.0%

    Best alignment

    Query 73 to 330, hit 45 to 302. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 104
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 164
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 224
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 284
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   285 CTGGAGAACTACTGCAAC 302
    

    258 of 258 identical, no gaps.

  4. EP 3220936-A22017-09-27

    ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

    PHASEBIO PHARMACEUTICALS INC

    Query Match 77.5%Identity 100.0%Family of 4

    Best alignment and family

    Query 73 to 330, hit 4 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 63
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    64 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 123
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   124 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 183
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 243
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   244 CTGGAGAACTACTGCAAC 261
    

    258 of 258 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, US 62/082945.

  5. US 9821036-B22017-11-21

    Therapeutic agents comprising a GLP-2 peptide and elastin-like peptides

    DUKE UNIVERSITY

    Query Match 77.5%Identity 100.0%

    Best alignment

    Query 73 to 330, hit 45 to 302. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 104
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 164
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 224
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 284
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   285 CTGGAGAACTACTGCAAC 302
    

    258 of 258 identical, no gaps.

  6. US 10596230-B22020-03-24

    Methods of increasing nutrient absorption in the intestine using therapeutic agents comprising GLP-2 and elastin-like peptides

    DUKE UNIVERSITY

    Query Match 77.5%Identity 100.0%

    Best alignment

    Query 73 to 330, hit 45 to 302. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 104
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 164
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 224
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 284
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   285 CTGGAGAACTACTGCAAC 302
    

    258 of 258 identical, no gaps.

  7. US 11103558-B22021-08-31

    Therapeutic agents comprising a BMP-9 peptide and eleastin-like peptides

    Duke University

    Query Match 77.5%Identity 100.0%

    Best alignment

    Query 73 to 330, hit 45 to 302. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 104
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 164
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 224
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 284
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   285 CTGGAGAACTACTGCAAC 302
    

    258 of 258 identical, no gaps.

  8. EP 2318432-A22011-05-11

    HALOGEN-STABILIZED INSULIN

    UNIV CASE WESTERN RESERVE

    Query Match 76.9%Identity 99.2%Family of 2

    Best alignment and family

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTAGACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    259 of 261 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  9. HALOGEN-STABILIZED INSULIN

    CASE WESTERN RESERVE UNIVERSITY

    Query Match 76.9%Identity 99.2%Family of 4

    Best alignment and family

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTAGACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    259 of 261 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, US 61/085212.

  10. US 9200053-B22015-12-01

    Insulin analogues containing penta-fluoro-Phenylalanine at position B24

    Case Western Reserve University

    Query Match 76.9%Identity 99.2%

    Best alignment

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTAGACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    259 of 261 identical, no gaps.

  11. JP 1999341991-A1999-12-14

    DNA encoding novel fused protein and process for producing useful protein mediating the expression thereof

    ITO HAM KK,JUZO UDAKA

    Query Match 76.7%Identity 99.6%

    Best alignment

    Query 73 to 330, hit 133 to 390. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   133 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 192
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   193 GAAAGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 252
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   253 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 312
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   313 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 372
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   373 CTGGAGAACTACTGCAAC 390
    

    257 of 258 identical, no gaps.

  12. US 6506595-A2003-01-14

    DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs

    Itoham Foods Inc.

    Query Match 76.7%Identity 99.6%

    Best alignment

    Query 73 to 330, hit 133 to 390. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   133 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 192
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   193 GAAAGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 252
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   253 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 312
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   313 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 372
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   373 CTGGAGAACTACTGCAAC 390
    

    257 of 258 identical, no gaps.

  13. Ramp Tag for Overexpressing Insulin and Method for Producing Insulin Using the Same

    POLUS Inc

    Query Match 76.6%Identity 100.0%

    Best alignment

    Query 73 to 327, hit 1 to 255. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGC 327
              |||||||||||||||
    Hit   241 CTGGAGAACTACTGC 255
    

    255 of 255 identical, no gaps.

  14. LIQUID INSULIN- CONTAINING COMPOSITIONS AND METHODS OF MAKING THE SAME

    ELONA BIOTECHNOLOGIES

    Query Match 76.4%Identity 98.9%

    Best alignment

    Query 72 to 333, hit 33 to 294. Positions start at 1 and include both ends.

    Query  72 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 131
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    33 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 92
    
    Query 132 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 191
              |||||||||||||||||||||||| |||||||||||||||||||||||||||||||||||
    Hit    93 GGAACGAGGCTTCTTCTACACACCGAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 152
    
    Query 192 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 251
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   153 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 212
    
    Query 252 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 311
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   213 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 272
    
    Query 312 GCTGGAGAACTACTGCAACTAG 333
              ||||||||||||||||  ||||
    Hit   273 GCTGGAGAACTACTGCGGCTAG 294
    

    259 of 262 identical, no gaps.

  15. US 5446020-A1995-08-29

    Method of treating diabetes with tissue-selective insulin analogs

    Query Match 76.1%Identity 100.0%

    Best alignment

    Query 73 to 333, hit 244 to 504. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              |||||||||||||||||||| || || |||||||||||||||||||||||||||||||||
    Hit   244 TTTGTGAACCAACACCTGTGTGGATCCCACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 303
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   304 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 363
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 423
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   424 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 483
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   484 CTGGAGAACTACTGCAACTAG 504
    

    258 of 261 identical, no gaps.

  16. EP 2509995-A22012-10-17

    INSULIN ANALOGUES WITH CHLORINATED AMINO ACIDS

    UNIV CASE WESTERN RESERVE

    Query Match 76.1%Identity 98.9%

    Best alignment

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    258 of 261 identical, no gaps.

  17. INSULIN ANALOGUES WITH CHLORINATED AMINO ACIDS

    CASE WESTERN RESERVE UNIVERSITY

    Query Match 76.1%Identity 98.9%Family of 3

    Best alignment and family

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    258 of 261 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  18. US 8399407-B22013-03-19

    Non-standard insulin analogues

    Case Western Reserve University

    Query Match 76.1%Identity 98.9%Family of 5

    Best alignment and family

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    258 of 261 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  19. JP 2014533241-A2014-12-11

    ULTRA-CONCENTRATED RAPID-ACTING INSULIN ANALOGUE FORMULATIONS

    Case Western Reserve University,Michael A Weiss

    Query Match 76.1%Identity 98.9%

    Best alignment

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    258 of 261 identical, no gaps.

  20. ULTRA-CONCENTRATED RAPID-ACTING INSULIN ANALOGUE FORMULATIONS

    CASE WESTERN RESERVE UNIVERSITY

    Query Match 76.1%Identity 98.9%Family of 2

    Best alignment and family

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    258 of 261 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  21. US 9758563-B22017-09-12

    Insulin analogues with chlorinated amino acids and nucleic acids encoding the same

    Case Western Reserve University

    Query Match 76.1%Identity 98.9%

    Best alignment

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    258 of 261 identical, no gaps.

  22. ASPART PROINSULIN COMPOSITIONS AND METHODS OF PRODUCING ASPART INSULIN ANALOGS

    ELONA BIOTECHNOLOGIES

    Query Match 75.7%Identity 98.5%

    Best alignment

    Query 72 to 333, hit 445 to 706. Positions start at 1 and include both ends.

    Query  72 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 131
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   445 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 504
    
    Query 132 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 191
              ||||||||||||||||||||||  ||||||||||||||||||||||||||||||||||||
    Hit   505 GGAACGAGGCTTCTTCTACACAGACAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 564
    
    Query 192 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 251
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   565 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 624
    
    Query 252 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 311
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   625 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 684
    
    Query 312 GCTGGAGAACTACTGCAACTAG 333
              ||||||||||||||||  ||||
    Hit   685 GCTGGAGAACTACTGCGGCTAG 706
    

    258 of 262 identical, no gaps.

  23. GLARGINE PROINSULIN COMPOSITIONS AND METHODS OF PRODUCING GLARGINE INSULIN ANALOGS THEREFROM

    ELONA BIOTECHNOLOGIES

    Query Match 75.7%Identity 98.5%

    Best alignment

    Query 72 to 333, hit 445 to 706. Positions start at 1 and include both ends.

    Query  72 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 131
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   445 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 504
    
    Query 132 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 191
              |||||||||||||||||||||||| || ||||||||||||||||||||||||||||||||
    Hit   505 GGAACGAGGCTTCTTCTACACACCGAACACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 564
    
    Query 192 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 251
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   565 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 624
    
    Query 252 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 311
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   625 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 684
    
    Query 312 GCTGGAGAACTACTGCAACTAG 333
              ||||||||||||||||  ||||
    Hit   685 GCTGGAGAACTACTGCGGCTAG 706
    

    258 of 262 identical, no gaps.

  24. JP 2000116392-A2000-04-25

    Novel vector

    PFIZER INC

    Query Match 74.9%Identity 98.1%

    Best alignment

    Query 72 to 333, hit 4 to 265. Positions start at 1 and include both ends.

    Query  72 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 131
              |||||||||||||||||||||||| || |||||||||||||||||| |||||||||||||
    Hit     4 CTTTGTGAACCAACACCTGTGCGGATCCCACCTGGTGGAAGCTCTCCACCTAGTGTGCGG 63
    
    Query 132 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 191
              |||||||||||||||||||||||||||||||||||||  |||||||||||||||||||||
    Hit    64 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGAGGGCAGAGGACCTGCAGGTGGG 123
    
    Query 192 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 251
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   124 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 183
    
    Query 252 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 311
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 243
    
    Query 312 GCTGGAGAACTACTGCAACTAG 333
              ||||||||||||||||||||||
    Hit   244 GCTGGAGAACTACTGCAACTAG 265
    

    257 of 262 identical, no gaps.

  25. EP 3356525-A12018-08-08

    COMPOSITIONS FOR ADJUSTABLE RIBOSOME TRANSLATION SPEED AND METHODS OF USE

    UNIV UTAH RES FOUND

    Query Match 74.9%Identity 98.1%

    Best alignment

    Query 72 to 333, hit 30 to 291. Positions start at 1 and include both ends.

    Query  72 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 131
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    30 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 89
    
    Query 132 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 191
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    90 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 149
    
    Query 192 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 251
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   150 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 209
    
    Query 252 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 311
              ||| ||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   210 GTCTCTGCAGGCGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 269
    
    Query 312 GCTGGAGAACTACTGCAACTAG 333
              ||||||||||||||||  ||||
    Hit   270 GCTGGAGAACTACTGCGGCTAG 291
    

    257 of 262 identical, no gaps.

  26. JP 2018529365-A2018-10-11

    COMPOSITIONS FOR ADJUSTABLE RIBOSOME TRANSLATION SPEED AND METHODS OF USE

    UNIVERSITY OF UTAH RESEARCH FOUNDATION

    Query Match 74.9%Identity 98.1%Family of 2

    Best alignment and family

    Query 72 to 333, hit 30 to 291. Positions start at 1 and include both ends.

    Query  72 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 131
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    30 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 89
    
    Query 132 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 191
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    90 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 149
    
    Query 192 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 251
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   150 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 209
    
    Query 252 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 311
              ||| ||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   210 GTCTCTGCAGGCGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 269
    
    Query 312 GCTGGAGAACTACTGCAACTAG 333
              ||||||||||||||||  ||||
    Hit   270 GCTGGAGAACTACTGCGGCTAG 291
    

    257 of 262 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  27. N-TERMINAL TRUNCATED INSULIN ANALOGUES

    CASE WESTERN RESERVE UNIVERSITY

    Query Match 74.3%Identity 97.7%Family of 3

    Best alignment and family

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              |||||   ||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTNNNCCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    255 of 261 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  28. Novel insulin analog and use thereof

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 3

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, KR 10-2014-0006937.

  29. long acting insulin and use thereof

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 3

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  30. Composition for Treating Diabetes Comprising Long-acting Insulin Analogue Conjugate and Long-acting Insulinotropic Peptide Conjugate

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 3

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  31. Composition for Treating Diabetes Mellitus Comprising Insulin and a GLP-1/glucagon dual agonist

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 2

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  32. Insulin analog

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  33. Novel Insulin Analogs and use thereof

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 2

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  34. Method of insulin production

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 2

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  35. EP 3148571-A12017-04-05

    COMPOSITION FOR TREATING DIABETES MELLITUS COMPRISING INSULIN AND A GLP-1/GLUCAGON DUAL AGONIST

    HANMI PHARM IND CO LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  36. EP 3156066-A12017-04-19

    COMPOSITION FOR TREATING DIABETES, CONTAINING LONG-ACTING INSULIN ANALOG CONJUGATE AND LONG-ACTING INSULIN SECRETION PEPTIDE CONJUGATE

    HANMI PHARM IND CO LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  37. EP 3341404-A12018-07-04

    NOVEL INSULIN ANALOGS AND USE THEREOF

    HANMI PHARM IND CO LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  38. EP 3341405-A12018-07-04

    METHOD OF INSULIN PRODUCTION

    HANMI PHARM IND CO LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  39. US 10017557-B22018-07-10

    Insulin analogs and use thereof

    HANMI PHARM. CO., LTD.

    Query Match 74.0%Identity 98.1%Family of 2

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  40. US 10159715-B22018-12-25

    Method for treating diabetes comprising long-acting insulin analogue conjugate and long-acting insulinotropic peptide conjugate

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  41. US 10188703-B22019-01-29

    Method for treating diabetes mellitus by a composition comprising insulin and a GLP-1/glucagon dual agonist

    HANMI PHARM. CO., LTD.

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  42. A long acting protein complex having an enhanced efficiency

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 2

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  43. A pharmaceutical composition comprising insulin and trigonal glucagon/GLP-1/GIP receptor agonist

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 2

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  44. A pharmaceutical composition comprising insulin and glucagon

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 3

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, KR 10-2018-0167798.

  45. EP 3689914-A12020-08-05

    PERSISTENT PROTEIN CONJUGATE WITH IMPROVED EFFICIENCY

    HANMI PHARM IND CO LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  46. A conjugate of insulin analog with reduced affinity to insulin receptor and use thereof

    HANMI PHARM. CO., LTD

    Query Match 73.7%Identity 98.1%Family of 4

    Best alignment and family

    Query 73 to 330, hit 1 to 258. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCGACCAG 240
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAAC 258
    

    253 of 258 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, KR 10-2017-0037101.

  47. EP 3517544-A12019-07-31

    INSULIN ANALOG HAVING REDUCED BINDING FORCE TO INSULIN RECEPTOR, AND USE THEREOF

    HANMI PHARM IND CO LTD

    Query Match 73.7%Identity 98.1%

    Best alignment

    Query 73 to 330, hit 1 to 258. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCGACCAG 240
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAAC 258
    

    253 of 258 identical, no gaps.

  48. JP 2019531075-A2019-10-31

    INSULIN ANALOG HAVING REDUCED BINDING FORCE TO INSULIN RECEPTOR, AND USE THEREOF

    HANMI PHARM CO LTD,Sanofi-Aventis Deutschland GmbH

    Query Match 73.7%Identity 98.1%

    Best alignment

    Query 73 to 330, hit 1 to 258. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCGACCAG 240
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAAC 258
    

    253 of 258 identical, no gaps.

  49. EP 3604328-A22020-02-05

    INSULIN ANALOG COMPLEX WITH REDUCED AFFINITY FOR INSULIN RECEPTOR AND USE THEREOF

    HANMI PHARM IND CO LTD

    Query Match 73.7%Identity 98.1%

    Best alignment

    Query 73 to 330, hit 1 to 258. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCGACCAG 240
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAAC 258
    

    253 of 258 identical, no gaps.

  50. US 11396534-B22022-07-26

    Insulin analogs with reduced affinity to insulin receptor and use thereof

    HANMI PHARM. CO., LTD. and SANOFI-AVENTIS DEUTSCHLAND GMBH

    Query Match 73.7%Identity 98.1%

    Best alignment

    Query 73 to 330, hit 1 to 258. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCGACCAG 240
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAAC 258
    

    253 of 258 identical, no gaps.